Buradasınız

Anasayfa » Content

Endometriumun preneoplastik ve neoplastik lezyonlarının ayırıcı tanısında AgNOR'un önemi

The value of AgNORs in differantiated preneoplastic and neoplastik endometrial lesions

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
The aim of the study was carried out to investigate the diagnostic value of the AgNOR to distinguishing between preneoplastic and neoplastic lesions of the endometrium. Retrospective analysis included tissue material obtalned from 50 patients with simple and complex hyperplasia with and without atypia and wsü differantiated endometrial adenocarcinoma. Sections were stained with AgNOR technigue. The results obtalned indicate that AgNOR counts have statistical significant in differantiating between well differantiated endometrial adenocarcinoma and, simple hyperplasia and complex hyperplasia with and without atypia.
Bookmark/Search this post with
Abstract (Original Language): 
Endometriumun preneoplastik ve neoplastik lezyonlarının ayırıcı tanısında AgNOR sayılarının önemini araştırmak amacıyla, basit endometrial hiperplazi (n=10), atipili basit endometria! hiperplazi (n=W), atipisiz kompleks hiper-plazi (n-10), atipili kompleks hiperplazi (n-10) ve iyi diferansiye endometrial adenokarsinom tanısı almış toplam 50 olgu AgNOR yöntemiyle boyandı. İyi diferansiye endometrial adenokarsinom ile karşılaştırıldığında atipili ve atipisiz basit hiperplazi ve kompleks hiperplazide görülen ortalama AgNOR sayılan arasında farklılık istatiksel olarak anlamlı bulundu (p<0.001).
FULL TEXT (PDF): 
PDF icon arastirmax-endometriumun-preneoplastik-neoplastik-lezyonlarinin-ayirici-tanisinda-agnorun-onemi.pdf
  • 2
79-81
  • Turkish

REFERENCES

References: 

1- Alan Rand Schenned, MD. Njcleolar Organizer Regions as Discriminations for the Diagnosis of Well 1-Differantiated Adenocarcinoma of the Prostate. Arch Patho! Lab Med 1993; 117:1000-4.
2- Crocker J, Ayresd Mc Goven J. Nucleolar Organizer Regions in Small Celi Carcinoma of the Bronchus. Thorax 1987: 42:972-5.
3- Crocker J, Boldly DAR, Ergan MJ. How Should We Count AgNORs Proposals for A Standartized Approach. J Pathol 1988; 158: 185-8.
4- Crocker J, Skillbeck N. Nucleolar Organizer Region Associated Proteins in Cutaneous Lesions. A Ouantitative Study. J Clin Pathol 1987; 40: 885-9.
5- Derenzini M, Persİon A, Farabegol F. Relationship Between Interphasic Nucleolar Organizer Regions and Growth Rate in Two Neuroblastoma Celi Lines. Am J Pathol 1989; 134: 4 : 925 32.
6- Deschenes J, VVeidner N. Nucleolar Organizer Regions (NOR) in Hyperplastic and Neoplastic Prostate Disease. Am J Surg Pathol 1990; 14:1148-55.
7- Egan MT, Raafat F, Crocker J, Nucleolar Organizer Regions in Fibrous Proiiferations of Childhood and Infantile Fibrosarcoma. J Clin Pathol 1988; 41: 31-3.
8- Derenzini M, Ploton D. Interphase Nucleolar Organizer Regions in Cancer Celis. Int Rev Exp Pathol 1991; 32 : 150-92.
9- Terlikowski S, Sulkowski S, Sulkowska M, Lenczewski A, Lotocki W. Differential Expression of AgNORs in Selected States of Endometrial Proliferation. Gin Pol 1996; 67: 141-5.
10- Trabucco S, Varcaccio-Garofalo G, Botticelia MA, De-Stefano R, Capursİ T, Resta L Expression of AgNORs in Serous Ovarian Tumors. Eur J Gynaecol Oncol 1994;3:222-9.
11- Aaltoma S, Lipponen P, Syrjanen K. Nucleolar Organizer Regions Related to Morphometry, Flow Cytometry, Sex Steroid Receptor Content, Tumour Histology and Prognosis in Female Breast Cancer, Pathol Res Pract 1993: 4: 416-21.
12- Ohri AK, Ohri SK, Herbert A, Royle G, Taylor I. The Relationship Between Clinical Staging, Oestrogen Receptor Status and Silver Binding Nucleolar Organizer Regions (AgNOR) in Breast Carcinoma. Eur J Surg Oncol 1992; 2 : 103-7.
13- Aubelc M, Auer G, Jutting U, Falkmar U, Gais P. Prognostic Value of Ouantatively Measured AgNORs İn Ductal Mammary Carcinoma. Anal Ouant Cytol Histol 1994; 3: 211-8.

14- Crİscuolo M, Martineili AM, Migaldi M, Zunarelli E, Bergamaschi M, Falchi AM, et al. Prognotic Significance of Nucleolar Organizer Region in Ovarian Epithelial Tumors. Int J Gynecol Patho! 1993; 3; 259-63.
15- Kenji Niwa. Yasuhim Yokoyoma,Takuji Tanaka, Hidehiro Mori, Hideki Mori Terufıİko Tamaya. Silver Stained Nucleolar Organİser Regions in the Normal, Hyperplastic and Neoplastic Endometrium. Vİrchovvs Archiv A Pathol Anat. 1991 ; 449: 493-7.
16- Egan M., Frecth M, and Crocker J. Relationship Between Intraepithelİal Neoplasia of the Cervİx and the Size and Number of Nucleolar Organizer Regions. Gynecol Oncol 1990 36; 30-3.
17- Stanwomir Teriikowski, Andrzej Lenczewski, Stanistaw Sulkowski, Marek Kulikowski. Nucleolar Organizer Regions in Differantiated Preneoplastic and Neoplastic Endometrial Lesions. Gynecol Oncol 1999; 47: 205-9.
18- Smith R, Crocker J. Evoluation The Nucleolar Organizer Region Associated Protein in Breast Malignancy. Histopathology 1988; 12: 113-25.
19- Soomro İN, VVhimster WF. Growth Fraction in Lung Tumours Determined by Kİ67 Immunostaining and
, Comparison VVith AgNOR Scores. J Pathol 1990; 162 : 217-22.
20- Crocker J, Paramjit N. Nucleolar Organizer Regions in Lymphomas. J Pathol 1987 ; 151 : 111 -8.
21 - Ayres JG, Crocker JG, Skillbeck NQ. Differrentiation of Malignant from Normal and Reactive Mesothelial Cells ■ by Argyrophil Tecnique for Nucleolar Organizer Region Associated Proteins . Thorax 1988; 43: 366-70.
22- Suarez V, Newman J, Hiley C, Crocker J, Collins M.
The Value of NOR Numbers in Neoplastic and
Nonneoplastic Epithelium of the Stomach.
Histopathology 1989; 14 : 61-6.
23- VVükinson N, Buckley HC, Chawner L, Fox H. Nucleolar
Organİser Regions in Normal, Hyperplastic and Neoplastic Endometrium. int Journal of Gynecological Pathoiogy I990 ; 9 : 55-9.
24- Terlikowski S, Lenczewskİ A, Famulski W, Sulkowski S, Kulikowski M. Expression of Nucleolar Organizer Regions (NORs) in Ovarian Epithelial Tumors. Folia Histochem Cytobiol. 2001 ; 39 (2) : 161-2.
25- Paul PC, Chattopadhyay A, Dutta SK, Mazumder DN,Santra A. Histopathology of Skin Lesions in Chronic Arsenic Toxicity-Grading of Changes and Study of Proliferative Markers. Indian J Pathol Microbiol. 2000 Jul ; 43 (3) : 257-64.

Thank you for copying data from http://www.arastirmax.com